Closed-loop insulin pump study after pancreas removal surgery
Part of Hormones & metabolism clinical trials.
This study tests a hybrid closed-loop insulin delivery system (MiniMed 780G with Simplera sensor) in people who have had their pancreas removed. The system automatically adjusts insulin based on glucose levels, which may make diabetes management easier and safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had your pancreas partially or fully removed, with very low C-peptide level (below 0.3 ng/mL) and blood sugar between 120 and 225 mg/dL at the time of testing.
- You use between 6 and 250 units of insulin daily.
- You are covered by French social security.
- You are willing and able to give written informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving insulin after pancreatic surgery helps control blood sugar in patients who develop diabetes as a result of the surgery. It may help you manage your recovery better and avoid complications from high blood sugar.
This study follows patients who are having part or all of their pancreas removed due to disease. Researchers want to understand how this surgery affects blood sugar control, weight, and overall health in people without diabetes before surgery.
This study looks at how different types of pancreatic surgery (removing part or all of the pancreas) affect blood sugar control in people who already have diabetes. It aims to understand how these operations change the body's metabolism and overall health, which may help improve care for patients.
This trial compares your current insulin pump therapy with a fully automated closed-loop system (artificial pancreas) that adjusts insulin using a smartphone algorithm. It aims to see which method works better for managing blood sugar levels in people with type 2 diabetes.
This trial tests a smart insulin pump system (hybrid closed-loop) to control blood sugar in people with type 2 diabetes who need surgery and will receive nutrition through a vein. It aims to prevent high and low blood sugar during and after surgery.
This study tests a new insulin pump system (MiniMed 780G) in children aged 7-17 who were recently diagnosed with type 1 diabetes. It aims to see if this pump helps control blood sugar better and improves quality of life compared to standard insulin shots or older pumps.
Hear when a new Pancreatectomy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.